Acid-base balance with different CAPD solutions.
Our objective is to investigate transperitoneal buffer fluxes with solution containing lactate and bicarbonate, and to compare the final effect on body base balance of the two solutions. One hundred and four exchanges, using different dwell times, were performed in 52 stable continuous ambulatory peritoneal dialysis (CAPD) patients. Dialysate effluent lactate and bicarbonate and volumes were measured. Net dialytic base gain was calculated. Patients' acid-base status and plasma lactate were determined. In lactate-buffer CAPD solution, lactate concentration in dialysate effluent inversely correlated with length of dwell time, but did not correlate with plasma lactate concentration and net ultrafiltration. Bicarbonate concentration in dialysate effluent correlated with plasma bicarbonate and dwell time but not with ultrafiltration. The arithmetic sum of the lactate gain and bicarbonate loss yielded the net dialytic base gain. Ultrafiltration was the most important factor affecting net dialytic base gain. A previous study demonstrated that in patients using a bicarbonate-buffered solution the net bicarbonate gain is a function of dwell time, ultrafiltration, and plasma bicarbonate. By combining the predicted data of the dialytic base gain with the calculated metabolic acid production, an approximate body base balance could be obtained with both lactate- and bicarbonate-buffered CAPD solutions. The body base balance in CAPD patients is self-regulated by the feedback between plasma bicarbonate concentration and dialytic base gain. The level of plasma bicarbonate is determined by the dialytic base gain and the metabolic acid production. This can explain the large interpatient variability in acid-base correction. Bicarbonate-buffered CAPD solution is equal to lactate solution in correcting acid-base disorders of CAPD patients.
Feriani
M
M
Department of Nephrology, St. Bortolo Hospital, Vicenza, Italy.
Ronco
C
C
La Greca
G
G
D000136:Acid-Base Equilibrium / Q000187:drug effects* / Q000502:physiology; D001639:Bicarbonates / Q000008:administration & dosage / Q000493:pharmacokinetics; D002245:Carbon Dioxide / Q000097:blood; D015314:Dialysis Solutions / Q000008:administration & dosage* / Q000493:pharmacokinetics; D006706:Homeostasis / Q000502:physiology; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007676:Kidney Failure, Chronic / Q000503:physiopathology*; D007773:Lactates / Q000008:administration & dosage / Q000493:pharmacokinetics; D019344:Lactic Acid; D010531:Peritoneal Dialysis, Continuous Ambulatory; D014882:Water-Electrolyte Balance / Q000187:drug effects / Q000502:physiology
D001639:Bicarbonates; D015314:Dialysis Solutions; D007773:Lactates; D002245:Carbon Dioxide; D019344:Lactic Acid